W Jaszcz

2.1k total citations
34 papers, 1.5k citations indexed

About

W Jaszcz is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, W Jaszcz has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in W Jaszcz's work include Toxin Mechanisms and Immunotoxins (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). W Jaszcz is often cited by papers focused on Toxin Mechanisms and Immunotoxins (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). W Jaszcz collaborates with scholars based in United States, Italy and France. W Jaszcz's co-authors include Fatih M. Uckun, Guido Pettinato, K Gajl-Peczalska, Damian E. Myers, J. Carlos Manivel, JA Ledbetter, John H. Kersey, Robert J. Gorlin, Emanuele S.G. dʼAmore and KG Waddick and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The American Journal of Surgical Pathology.

In The Last Decade

W Jaszcz

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Jaszcz United States 21 561 371 300 283 255 34 1.5k
J. U. Gutterman United States 29 880 1.6× 430 1.2× 518 1.7× 227 0.8× 331 1.3× 58 2.2k
Sharon R. Hymes United States 22 494 0.9× 415 1.1× 167 0.6× 235 0.8× 174 0.7× 57 2.0k
A Bussel France 21 220 0.4× 523 1.4× 273 0.9× 168 0.6× 346 1.4× 82 1.8k
A. Le Tourneau France 20 379 0.7× 217 0.6× 146 0.5× 460 1.6× 128 0.5× 83 1.2k
Gerald E. Byrne United States 27 959 1.7× 475 1.3× 244 0.8× 1.4k 4.8× 213 0.8× 48 2.3k
Tim H. Parmley United States 26 245 0.4× 197 0.5× 314 1.0× 168 0.6× 193 0.8× 74 1.8k
Stuart D. Flynn United States 28 625 1.1× 163 0.4× 358 1.2× 414 1.5× 248 1.0× 60 2.3k
Mary V. Gresik United States 17 597 1.1× 306 0.8× 308 1.0× 353 1.2× 227 0.9× 40 1.8k
S Pileri Italy 17 337 0.6× 180 0.5× 121 0.4× 449 1.6× 179 0.7× 36 1.3k
Nicole Brousse France 17 265 0.5× 301 0.8× 174 0.6× 280 1.0× 112 0.4× 42 1.1k

Countries citing papers authored by W Jaszcz

Since Specialization
Citations

This map shows the geographic impact of W Jaszcz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Jaszcz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Jaszcz more than expected).

Fields of papers citing papers by W Jaszcz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Jaszcz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Jaszcz. The network helps show where W Jaszcz may publish in the future.

Co-authorship network of co-authors of W Jaszcz

This figure shows the co-authorship network connecting the top 25 collaborators of W Jaszcz. A scholar is included among the top collaborators of W Jaszcz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Jaszcz. W Jaszcz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallera, Daniel A., Michael K. Elson, Martin W. Brechbiel, et al.. (2004). Radiotherapy of CD19 Expressing Daudi Tumors in Nude Mice with Yttrium-90-Labeled Anti-CD19 Antibody. Cancer Biotherapy and Radiopharmaceuticals. 19(1). 11–23. 14 indexed citations
2.
Clark, John L., Phuong Nguyen, W Jaszcz, Aminah Jatoi, & Gloria A. Niehans. (2000). Prognostic Variables in Male Breast Cancer. The American Surgeon. 66(5). 502–511. 27 indexed citations
3.
Tomasik, Bartłomiej, T Zebro, & W Jaszcz. (1998). [Malignant leiomyoma of the inferior vena cava with the clinical picture of Budd-Chiari syndrome].. PubMed. 11. 443–53.
4.
Stroncek, David F., et al.. (1998). Expression of neutrophil antigens after 10 days of granulocyte‐colony‐stimulating factor. Transfusion. 38(7). 663–668. 52 indexed citations
5.
Stroncek, David F., et al.. (1997). Comparison of two blood cell separators in collecting peripheral blood stem cell components. Transfusion Medicine. 7(2). 95–99. 25 indexed citations
6.
Stroncek, DF, Mary Clay, Judith A. Smith, et al.. (1997). The kinetics of G‐CSF mobilization of CD34+ cells in healthy people. Transfusion Medicine. 7(1). 19–24. 42 indexed citations
7.
Uhlman, Dorothy L., George L. Adams, Jeffrey M. Resnick, et al.. (1995). Cervical Lymph Node Status and Survival in Laryngeal Carcinoma: Prognostic Factors. Annals of Otology Rhinology & Laryngology. 104(9). 685–694. 39 indexed citations
8.
Nguyen, Phuong L., Paul E. Swanson, W Jaszcz, et al.. (1994). Expression of Epidermal Growth Factor Receptor in Invasive Transitional Cell Carcinoma of the Urinary Bladder:A Multivariate Survival Analysis. American Journal of Clinical Pathology. 101(2). 166–176. 102 indexed citations
9.
Coffin, Cheryl M., W Jaszcz, Patricia O’Shea, & Louis P. Dehner. (1994). So-Called Congenital-Infantile Fibrosarcoma: Does It Exist and What Is It?. Pediatric Pathology. 14(1). 133–150. 96 indexed citations
10.
Jansen, Burkhard, John H. Kersey, W Jaszcz, et al.. (1993). Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide.. PubMed. 7(2). 290–7. 30 indexed citations
11.
Uckun, Fatih M., et al.. (1993). Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.. Journal of Clinical Investigation. 91(3). 1044–1051. 29 indexed citations
12.
Jansen, Burkhard, Daniel A. Vallera, W Jaszcz, Dat Nguyen, & John H. Kersey. (1992). Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.. PubMed. 52(5). 1314–21. 44 indexed citations
13.
Pettinato, Guido, J. Carlos Manivel, Emanuele S.G. dʼAmore, W Jaszcz, & Robert J. Gorlin. (1991). Melanotic Neuroectodermal Tumor of Infancy. The American Journal of Surgical Pathology. 15(3). 233–245. 68 indexed citations
14.
Pettinato, Guido, et al.. (1991). Melanotic neuroectodermal tumor of infancy. A reexamination of a histogenetic problem based on immunohistochemical, flow cytometric, and ultrastructural study of 10 cases.. PubMed. 15(3). 233–45. 83 indexed citations
15.
16.
Hanson, Curtis A., W Jaszcz, John H. Kersey, et al.. (1989). True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysis. British Journal of Haematology. 73(2). 187–198. 45 indexed citations
17.
18.
Uckun, Fatih M., W Jaszcz, K Gajl-Peczalska, et al.. (1988). Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti- CD19 immunotoxins. Blood. 71(1). 13–29. 18 indexed citations
19.
Jaszcz, W, et al.. (1980). [Studies on the biological activity of thymus gland extracts (TFX). II. Effect of TFX on the blood and lymphatic organ picture of thymectomized mice in the post-neonatal period].. PubMed. 31(2). 273–85. 1 indexed citations
20.
Kulig, Andrzej, et al.. (1964). MALIGNANT TUMORS IN THE AUTOPSY MATERIAL OF THE DEPARTMENT OF PATHOLOGICAL ANATOMY OF THE MEDICAL ACADEMY IN CRACOW IN THE YEARS 1939--1958. 2. A STATISTICAL ANALYSIS OF CANCER METASTASES BASED ON AUTOPSY PROTOCOLS.. PubMed. 5. 139–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. U. Gutterman Breakdown of academic impact, for papers by Sharon R. Hymes Breakdown of academic impact, for papers by A Bussel Breakdown of academic impact, for papers by A. Le Tourneau Breakdown of academic impact, for papers by Gerald E. Byrne Breakdown of academic impact, for papers by Tim H. Parmley Breakdown of academic impact, for papers by Stuart D. Flynn Breakdown of academic impact, for papers by Mary V. Gresik Breakdown of academic impact, for papers by S Pileri Breakdown of academic impact, for papers by Nicole Brousse
Rankless by CCL
2026